NO974256L - Anvendelse av anti-östrogener som befruktningshindrende midler for menn - Google Patents

Anvendelse av anti-östrogener som befruktningshindrende midler for menn

Info

Publication number
NO974256L
NO974256L NO974256A NO974256A NO974256L NO 974256 L NO974256 L NO 974256L NO 974256 A NO974256 A NO 974256A NO 974256 A NO974256 A NO 974256A NO 974256 L NO974256 L NO 974256L
Authority
NO
Norway
Prior art keywords
contraceptives
estrogens
men
antiestrogens
production
Prior art date
Application number
NO974256A
Other languages
English (en)
Norwegian (no)
Other versions
NO974256D0 (no
Inventor
Ursula Friederike Habenicht
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO974256D0 publication Critical patent/NO974256D0/no
Publication of NO974256L publication Critical patent/NO974256L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Junction Field-Effect Transistors (AREA)
NO974256A 1995-03-16 1997-09-15 Anvendelse av anti-östrogener som befruktningshindrende midler for menn NO974256L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19510862A DE19510862A1 (de) 1995-03-16 1995-03-16 Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
PCT/EP1996/001191 WO1996028154A2 (de) 1995-03-16 1996-03-15 Verwendung von antiestrogenen zur männlichen fertilitätskontrolle

Publications (2)

Publication Number Publication Date
NO974256D0 NO974256D0 (no) 1997-09-15
NO974256L true NO974256L (no) 1997-11-14

Family

ID=7757669

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974256A NO974256L (no) 1995-03-16 1997-09-15 Anvendelse av anti-östrogener som befruktningshindrende midler for menn

Country Status (21)

Country Link
US (1) US20010056086A1 (pl)
EP (1) EP0814803B1 (pl)
JP (1) JPH11501648A (pl)
KR (1) KR19980703057A (pl)
CN (1) CN1151792C (pl)
AT (1) ATE342055T1 (pl)
CA (1) CA2215373A1 (pl)
CZ (1) CZ293771B6 (pl)
DE (2) DE19510862A1 (pl)
DK (1) DK0814803T3 (pl)
ES (1) ES2275273T3 (pl)
HU (1) HUP9900313A3 (pl)
IL (1) IL117515A (pl)
NO (1) NO974256L (pl)
NZ (1) NZ303672A (pl)
PL (1) PL186085B1 (pl)
PT (1) PT814803E (pl)
SK (1) SK284442B6 (pl)
TW (1) TW503106B (pl)
WO (1) WO1996028154A2 (pl)
ZA (1) ZA962176B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
EP2258375A1 (de) 2009-06-04 2010-12-08 Bayer Schering Pharma Aktiengesellschaft 17B-alkyl-17alpha-oxy-estratriene

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3213328A1 (de) * 1982-04-06 1983-10-06 Schering Ag 3,4,17-trioxygenierte 4,9(11)-androstadiene
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5166201A (en) * 1990-11-30 1992-11-24 Merrell Dow Pharmaceuticals Inc. 2β,19-ethylene bridged steroids as aromatase inhibitors
FR2685332A1 (fr) * 1991-12-20 1993-06-25 Roussel Uclaf Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.

Also Published As

Publication number Publication date
ATE342055T1 (de) 2006-11-15
AU5004696A (en) 1996-10-02
CZ293771B6 (cs) 2004-07-14
PL322253A1 (en) 1998-01-19
HUP9900313A1 (hu) 1999-06-28
ES2275273T3 (es) 2007-06-01
MX9707008A (es) 1997-11-29
SK284442B6 (sk) 2005-04-01
IL117515A (en) 2003-07-31
DE59611391D1 (de) 2006-11-23
DE19510862A1 (de) 1996-09-19
ZA962176B (en) 1996-07-29
CN1178463A (zh) 1998-04-08
SK123897A3 (en) 1998-02-04
NZ303672A (en) 2000-07-28
KR19980703057A (ko) 1998-09-05
JPH11501648A (ja) 1999-02-09
AU713467B2 (en) 1999-12-02
CA2215373A1 (en) 1996-09-19
TW503106B (en) 2002-09-21
US20010056086A1 (en) 2001-12-27
WO1996028154A2 (de) 1996-09-19
CN1151792C (zh) 2004-06-02
IL117515A0 (en) 1996-07-23
PL186085B1 (pl) 2003-10-31
EP0814803A2 (de) 1998-01-07
CZ285297A3 (en) 1997-12-17
NO974256D0 (no) 1997-09-15
DK0814803T3 (da) 2007-02-19
WO1996028154A3 (de) 1997-05-01
EP0814803B1 (de) 2006-10-11
HUP9900313A3 (en) 1999-11-29
PT814803E (pt) 2007-02-28

Similar Documents

Publication Publication Date Title
BR0010215A (pt) Derivados de indolina como antagonistas de progesterona
DE69531998D1 (de) Steroidrezeptor-modulator verbindungen und methoden
NO20041503L (no) Pyrimidinoner som melanin konsentrerende hormon reseptor 1
NO20034289D0 (no) N-(2-aryletylbenzylaminer som antagonister av 5-HT6- reseptoren
DE69732868D1 (de) Mittel gegen Juckreiz
ES2174629T3 (es) 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos.
NO20030374L (no) Syklopentanoindoler, preparater som inneholder slike forbindelser og behandlingsfremgangsmåter
MXPA03004549A (es) Derivados de 3-arilindola y su uso como agonistas del receptor cb2.
DK0806952T3 (da) Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger
NO994850L (no) Farmakologiske midler
NO943133L (no) Benzodiazepinderivater egnet til bruk som CCK-reseptorantagonister
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
NO974256D0 (no) Anvendelse av anti-östrogener som befruktningshindrende midler for menn
AU1791497A (en) At1 receptor antagonist for the stimulation of apoptosis
ATE420649T1 (de) Verwendung von (11beta, 17beta)-11-(1,3- benzodioxol-5-yl)-17-hydroxy-17-(1-propinyl)- estra-4,9-dien-3-on zur behandlung von schweren depressionen
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
NO20023841L (no) Anvendelse av glukokortikoidreseptorantagonister for forebygging og behandling av sykdommer av reproduksjonssystemet hos menn
NO20022712D0 (no) Umettede 14,15-syklopropanandrostaner, fremgangsmåte for deres fremstilling, og farmasöytiske preparater som inneholderdisse forbindelsene
DK1365768T3 (da) Anvendelse af ER-beta-selektive antagonister som contraception.
ECSP003598A (es) Derivados de 1,5- dihidropirrol-2-ona sustituida, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estos compuestos para la preparacion de medicamentos
AR011169A1 (es) Compuestos derivados de quinoxalinadionas, su uso para la preparacion de medicamentos, compuestos intermediarios y procedimiento para preparar dichos medicamentos
UY27406A1 (es) Derivados de 2h-1-benzopirano, procesos para su preparación y composiciones farmacéuticas que los contienen
RU97117160A (ru) Применение антиэстрогенов для контроля мужской фертильности

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application